European Biotechnology
Thematic Network Association

Munis Dündar

PRESIDENT

He was born May 2, 1961. He took an undergraduate degree at Erciyes University, Faculty of Medicine in 1985. He made Ph.D. on Medical Genetics at Duncan Guthrie Institute of Medical Genetics, University of Glasgow/Scotland in 1994 and got Professor Title in 2003. He is founder and head of Medical Genetics Department at Erciyes University and he has been currently carrying out various administrative tasks since 1996. 

He took part as Project Coordinator and Assistant Investigator in many research projects and many prepared articles out of them have been publishing in international journals since 1995.  He is a lecturer at European University Consortium, Job Creation Oriented Biotechnology for first-level degree and master program students, since 2006. He is president of the Turkish Medical Genetic Society, representative of EPMA in Turkey and EBTNA President (European Biotechnology Thematic Network Association).

Oscar Vicente

VICE PRESIDENT

Oscar Vicente was born in 1956, in Madrid (Spain), where he graduated in Biochemistry in 1976 and obtained his PhD in Sciences in 1983. After a three-year postdoctoral period at the Friedrich-Miescher Institut, in Basel (Switzerland), in 1988 Oscar Vicente moved to the Institute of Microbiology and Genetics, University of Vienna (Austria), where he established and led a research group working on different aspects of plant reproductive biology and its biotechnological applications, and on the molecular characterization of pollen allergens and plant MAP kinases. As Assistant Professor, from 1991 to 1996, he was responsible for several courses of Experimental Genetics taught at the Faculty of Sciences. Oscar Vicente returned to Spain in 1996, to join the faculty of the Polytechnic University of Valencia, where he is at present Professor of Biochemistry and Molecular Biology at the Department of Biotechnology, teaching different subjects in this area to students of Biotechnology and Biomedical Engineering. His research interest focuses on the study of plant responses to abiotic stress and stress tolerance mechanisms. Oscar Vicente has published more than 100 ISI-indexed scientific papers, many of them in top journals, such as Plant Cell, Plant Journal, Plant Physiology, Frontiers in Plant Science or PLoS ONE. Oscar Vicente is Vice-president and coordinator for Spain of the European Biotechnology Thematic Network Association (EBTNA). In 2017, he was awarded the degree of Doctor Honoris Causa by the University of Agricultural Sciences and Veterinary Medicine, Cluj-Napoca (Romania).

 

 

Donald Martin

SECRETARY-GENERAL

Prof. Martin received a bachelors degree in optometry, a masters degree in biomedical engineering and a PhD in biomechanics of contact lenses/biophysics of the anterior eye from the University of New South Wales (Australia). He was awarded the inaugural Medical Foundation Post-Doctoral Fellowship (3 years) to complete postdoctoral training in electrophysiology at the University of Sydney. He then continued the first part of his career in Australia, until 2008, with scientific and academic positions at St Vincent’s Hospital Sydney and the University of Technology Sydney. From 2003-2008 he was an executive board member of the Australian French Association for Science and Technology (AFAS NSW). In 2005 he initiated the Australian network in nanobiotechnology called OzNano2Life, which directly funded postdoctoral researchers in several universities and institutions across Australia and provided the portal for exchanging structured scientific information with nanotechnology institutes in Europe. In 2009 he was awarded a French Chaire d’Excellence to establish a research program in nanobiosciences at the Fondation Nanosciences and the Université Grenoble Alpes. In 2013 he was appointed to the continuing position of Professeur des Universités, Université Grenoble Alpes. He also has an honorary position at the University of Melbourne (Australia). He is the co-author on 11 patents, more than 100 publications and is co-founder in 3 Australian startups. His book on nanobiotechnology published by Springer in 2007 was translated to Russian and published in 2012 by Nauchny Mir, Moscow.

Tommaso Beccari

TREASURER

Professor Tommaso Beccari has a long experience on lysosomal enzymes that begun in 1985 at the King’s College of London UK in the laboratories of Prof. D. Robinson and Dr. JL Stirling, two pioneers in the field of lysosomes. 

He has been Visiting Professor at the King’s College, London, UK; Universitè Renè Descartes, Paris, France; Georg-August-Universitat Gottingen, Germany; University of Tromso, Norway. His research has been focused on the biochemistry and molecular biology of lysosomal enzymes and to study the pathophysiology of the lysosomal storage disorders. More recently his laboratory has participated to the development of a therapy for the lysosomal storage disease, alpha-mannosidosis. 

His laboratory is involved in the diagnosis of alpha-mannosidosis, beta-mannosidosis, mucolipidosis type II and III. Part of his research is oriented to analyses the relationship between lysosomal enzymes and Parkinson’s Disease. More recently two new ko mice for the chitobiose and cytoplasmic alpha-mannosidase have been generated in order to better understand the catabolism of oligosaccharides. Finally, another topic of his research is on the genetic association of Anorexia nervosa and Bulimia Nervosa. 

Professor Tommaso Beccari is the author of several papers published in leading international journals

Anita Slavica

MEMBER

Anita Slavica was born in 1970 in Šibenik, Croatia. After degrees in Biotechnology (BSc and MSc) at Faculty of Food Technology and Biotechnology, University of Zagreb, she took Ph.D. in Technical Chemistry at Graz University of Technology, Austria. She habilitated in 2006 in Physiology of Industrial Microorganisms at Department of Biochemical Engineering, the Faculty of Food Technology and Biotechnology, University of Zagreb. Since 2011 she is working as Associate Professor in Laboratory of Biochemical Engineering, Industrial Microbiology, Malting, and Brewing Technology at the Department. She is a lecturer at „Bioprocess Engineering“ and „Molecular Biotechnology“ MSc degree studies program and „Biotechnology and Bioprocess Engineering“ Ph.D. program, a researcher in several national/international research projects, supervisor of undergraduate and graduate students, and member of international conferences organizing and scientific comities. Scientific fields of her interest are mass spectrometry; development and application of analytical methods related to the monitoring of sustainable bioprocesses for production of biochemicals; protein expression, purification, and characterization; enzyme kinetics; biochemical engineering and industrial microbiology; TT and IPR.

Juraj Krajcovic

MEMBER

Dr. Juraj Krajcovic is a Professor of Molecular biology and Chairperson of the Institute of Cell Biology and Biotechnology at the Faculty of Natural Sciences, Comenius University in Bratislava, Slovakia. He received his Ph.D. from Comenius University in 1987. He was a postdoctoral fellow at the International Institute of Cellular and Molecular Pathology in Brussels, Belgium (1990-1993). 

Current Research Interests: Molecular cell biology; gene expression; protein import into organelles, primarily chloroplasts; molecular diagnostics; molecular evolution and systematics, DNA identification of microorganisms, especially lactic acid bacteria and phototrophs; plastids as drug targets; the origin and evolution of the cell; antimutagenicity; extremophiles. Teaching activities: Molecular cell biology, Evolutionary biology; Selected chapters in microbiology; Selected chapters in biotechnology; Molecular methods in systematic biology.

Dana Tapaloaga

MEMBER

Dr. Dana Tapaloaga is Full Professor at the Faculty of Veterinary Medicine, Bucharest. She took her Ph.D. in Veterinary Medicine in 2004 in the field of Animal Reproduction Biotechnology, and her MSc in 1999 (Reproduction BioTechniques and Biotechnologies) and 1996 (Milk production, processing, and trading).

Professional teaching experience area: Milk and meat obtaining technologies, Animal Production Systems, Animal Genetics, Animal breeding. Current Research interests:  laboratory and economic efficiency researches on bull, buffalo and boar semen; computerized studies on bull and boar semen; laboratory technologies for reproduction biotechnology in breeds preserving; morphologic and hormonal modifications in cows with puerperal disorders; certification and preserving the genetic potential in Mangalitza breed by biotechnological methods.

She was a postdoctoral researcher in the field of animal biodiversity at Postdoctoral School for Animal Sciences Biodiversity and Food Sciences Biotechnologies based upon eco economy and bio-economy required to eco san genesis at Romanian Academy, member of Romanian Animal Science Association, member of World Poultry Science Association, member of DAGENE (International Association for the Conservation of Animal Breeds in the Danube Region), member of the Academy of Romanian Scientists, the Committee of National Food Security.

Mark Nuijten

MEMBER

Dr. Mark Nuijten trained as a physician and worked in clinical practice before obtaining an international M.B.A. from Erasmus University, Rotterdam, with a focus on financial management. He obtained his Ph.D. in health economics (2003) on the thesis “In search of more confidence in health economic modeling” at the Erasmus University, Rotterdam. Dr. Nuijten has become one of the top health economic experts over the last decade, reflected in more than 180 publications and leading positions in scientific societies and editorial boards. Dr. Nuijten was Board Director of ISPOR (2002-2004) and Chair of the Management Board of Value in Health (2002-2004). He was a member of the Editorial Advisory Board of Value in Health. Dr. Nuijten is internationally renowned for achievements in mathematical modeling, also reflected in many publications and positive reimbursement decisions in many markets for innovative medications by institutions, like NICE in England.

He is a pioneer in the field of healthcare innovation in biotechnology and nutrition and has been the first classical health economist successfully applying and developing sales forecast methodologies for valuation of biotechnology companies. For example, developing a Pricing Matrix Model for research in early phase development and a Financial Valuation Algorithm for the assessment of the future sales of a new, innovative medicinal product. Dr. Nuijten is pursuing the development of economic modeling and broadening its application in health care and finance. His models successfully contributed to positive reimbursement decisions by health authorities in many countries, (for example, SMC in Scotland, TLV in Sweden, and The National Health Care Institute in The Netherlands).

He is the academic supervisor of Ph.D. programs at the Universities of Maastricht and Groningen in The Netherlands and founder of the ISPOR Special Interest Group on nutrition-economics. Dr. Nuijten owns and runs A2M (Ars Accessus Medica - http://a2m.nl/), which provides international consulting services in health economics, pricing, market access and valuation in biotechnology. A2M is a partner of Minerva, an international health economics consortium. A2M established other global collaborations with key opinion formers in key European markets, the US, Canada, and Japan. A2M is comfortable with multi-country projects. The current A2M project portfolio reflects its long-time international coverage with health economic models being developed for Russia, Italy, Mexico, UK, France, Netherlands, and Belgium.

Prior to setting up A2M, Dr. Nuijten was a partner with MEDTAP International. As a VP Business Development for Europe, he established global Pricing and Reimbursement Consultancy Services for MEDTAP. Before MEDTAP, Dr. Nuijten was a Managing Director of the Quintiles office in the Netherlands.

Gary Henehan

MEMBER

Professor Henehan has experience of research and development in academia and in the food, pharmaceutical and biotechnology industries. He lectures in biochemical, toxicological and pharmacological aspects of Food Science and Environmental Health. His research includes collaborative work with the School of Biochemistry and Immunology at Trinity College Dublin and the School of Biotechnology, Dublin City University.

Ivana Marova

MEMBER

Prof. Ivana Marova is a regular professor of biochemistry at Faculty of Chemistry, Brno University of Technology (FCH BUT). At this time she is a Head of Department of Food Chemistry and Biotechnology, FCH BUT. She has been profiled as a specialist in the field of microbial biochemistry and biotechnology, food biochemistry, bioanalysis and utilization/valorization of waste substrates to the production of high value-added products.  She has worked as the leader of research groups in the frame of national and international projects from 2002 till present.  At this time she is a head of the Biotechnology and Biomaterials group of Materials Research Centre FCH BUT in Brno (established in 2010 as a regional center of excellence); she is a leader of the research group working on the development of patented HYDAL biotechnology awarded by Frost and Sullivan Technology Innovation Award (2015). She was the applicant and co-applicant of many scientific projects (ESF, GACR, TACR, OP VaVpI). She is the author of about 100 original scientific papers, 4 books/chapters, 2 accepted and 4 applied patents, 2 industrial applications and co-author of about 300 contributions on international conferences. She is the supervisor of doctoral students DSP (more than 20 successfully defended Ph.D. theses). She cooperates with many industrial subjects (Nafigate, a.s., Pharmaceutical Biotechnology) and international research groups.

The Brno University of Technology (BUT), the second-largest technical university in the Czech Republic, was found in 1899 as the first Czech higher education institution in the Moravia region. At the present time, more than 24,000 students are enrolled at BUT at 8 faculties and 2 university institutes.